Company Filing History:
Years Active: 1988-2010
Title: Dennis M. Schmatz: Innovator in Antiprotozoal Therapeutics
Introduction
Dennis M. Schmatz is a prominent inventor based in Cranford, NJ, with a remarkable portfolio of 18 patents. His work primarily focuses on developing therapies targeting protozoal diseases, showcasing his dedication to advancing medical science and public health.
Latest Patents
Among his latest patents is the innovation titled "Toxoplasma gondii cyclic GMP dependent protein kinase G as a chemotherapeutic target for antiprotozoal agents." This patent emphasizes the potential of protozoal cyclic GMP dependent protein kinases in screening assays for identifying new antiprotozoal agents. Furthermore, he has developed antiprotozoal imidazopyridine compounds, which are described by specific chemical formulas and recognized for their efficacy in treating and preventing protozoal diseases in mammals and birds. His methodologies also encompass controlling coccidiosis in poultry, where he proposes administering these compounds alone or in conjunction with other anticoccidial agents.
Career Highlights
Dennis has made significant contributions through his work with reputable companies such as Merck & Company, Inc. and Merial Limited. His extensive experience in the pharmaceutical field has been instrumental in the discovery and development of therapeutic agents aimed at combating various protozoal infections.
Collaborations
Throughout his career, Dennis has collaborated with talented professionals, including Sandra J. Rattray and Anne M. Gurnett. These partnerships have bolstered his research and innovation efforts, leading to meaningful advancements in the field of antiprotozoal therapeutics.
Conclusion
In summary, Dennis M. Schmatz stands out as an influential inventor in the realm of medical research. With his 18 patents to his name and dedication to addressing protozoal diseases, he continues to contribute to the health and well-being of both humans and animals. His work exemplifies the importance of innovation in the fight against infectious diseases and highlights the role of collaborative efforts in scientific advancements.